Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Pedersen

Showing results (441-450 of 448) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 448 results.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
BMJ Open|October 16, 2024
Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry DataRuth E Costello, Lars Pedersen, Alasdair D Henderson, et al.
The European Respiratory Journal|August 7, 2025
Pulmonary pressure increases during Acute Exacerbation in Chronic Obstructive Pulmonary Disease and clinical outcomeEma Rastoder, Pradeesh Sivapalan, Caroline Hedsund, et al.
The European Respiratory Journal|June 4, 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, et al.
Trials|June 12, 2020
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, et al.
Trials|September 27, 2022
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trialJosefin Eklöf, Imane Achir Alispahic, Pradeesh Sivapalan, et al.
Vaccine|August 21, 2018
Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessmentDaniel Weibel, Miriam Sturkenboom, Steven Black, et al.
Pageof 45

Showing results (441-450 of 448) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 448 results.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
BMJ Open|October 16, 2024
Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry DataRuth E Costello, Lars Pedersen, Alasdair D Henderson, et al.
The European Respiratory Journal|August 7, 2025
Pulmonary pressure increases during Acute Exacerbation in Chronic Obstructive Pulmonary Disease and clinical outcomeEma Rastoder, Pradeesh Sivapalan, Caroline Hedsund, et al.
The European Respiratory Journal|June 4, 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, et al.
Trials|June 12, 2020
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, et al.
Trials|September 27, 2022
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trialJosefin Eklöf, Imane Achir Alispahic, Pradeesh Sivapalan, et al.
Vaccine|August 21, 2018
Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessmentDaniel Weibel, Miriam Sturkenboom, Steven Black, et al.
Pageof 45